Fundamentals of Anticancer Therapy Day 1 - Enduring Material - Credit offering period - June 26, 2026 - December 31, 2026
Overview of Anticancer Therapies
Mary E. Kern, MSN, RN, OCN, CHSE
*scientific basis, diagnosis, staging
Myelosuppression and Overview of Growth Factors
Danielle Roman, Clinical Pharmacist Specialist, BCOP
*treatment/symptom management
Cell-Cycle Specific Agents Plant Alkaloids, Antimetabolites, Miscellaneous Agents and Nursing Implications
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Toxicity Assessments
Marcia Almiron-Wolbert, MSN, RN, OCN
*treatment/symptom management
Additional Information
| Attachment | Size |
|---|---|
| 2.22 MB | |
| 21.74 MB | |
| 3.62 MB |
Course summary
- 5.25 AMA PRA Category 1 Credit™
- 5.25 Attendance
- 5.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 5.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 5.25 AMA PRA Category 1 Credit™
- 5.25 Attendance
- 5.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Facebook
X
LinkedIn
Forward